Clinical benefits and potential risks of adalimumab in non-JIA chronic paediatric uveitis

Carlyn V. Kouwenberg*, Viera Koopman-Kalinina Ayuso, Joke H. de Boer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Clinical benefits and potential risks of adalimumab in non-JIA chronic paediatric uveitis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology